Stay updated on Comparing Crenolanib vs Midostaurin in AML Clinical Trial
Sign up to get notified when there's something new on the Comparing Crenolanib vs Midostaurin in AML Clinical Trial page.

Latest updates to the Comparing Crenolanib vs Midostaurin in AML Clinical Trial page
- Check5 days agoChange DetectedThe study record now shows that recruitment is closed for this trial. The history also updates the page revision to v3.6.0 and removes the previous revision v3.5.5, reflecting changes to the page rather than the study itself.SummaryDifference0.3%

- Check12 days agoChange DetectedA new revision entry v3.5.5 has been added to the record history, updating the study record to the latest version and superseding the prior v3.5.4.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedNew revision v3.5.4 was added to the record history, replacing the previous v3.5.3. This reflects a minor update to the page's release notes in the history view.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page’s displayed ClinicalTrials.gov revision/version number has been updated from v3.5.2 to v3.5.3, reflecting a site software update rather than a change to the study record itself.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded revision: v3.5.2 and removed revision: v3.5.0 from the history.SummaryDifference0.1%

- Check70 days agoChange DetectedAdded Contacts/Locations, Study Status, and Study Design sections to the record history; removed Recruiting status and related entries (including Arog Pharmaceuticals, Inc., 2020-05-22, and verification notes).SummaryDifference1%

Stay in the know with updates to Comparing Crenolanib vs Midostaurin in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing Crenolanib vs Midostaurin in AML Clinical Trial page.